Scynexis (SCYX) Other financing activities (2014 - 2026)
Scynexis (SCYX) posted Other financing activities of $17000.0 for Q1 2026, down 32.0% on a QoQ basis from $25000.0 in Q3 2025, and down 34.62% year-over-year from $26000.0 in Q1 2025.
Scynexis (SCYX) Other financing activities (2014 - 2026) Analysis & Trends
Scynexis' Other financing activities history runs 13 years deep, the most recent figure standing at $17000.0 for Q1 2026.
- Quarterly Other financing activities fell 34.62% year-over-year to $17000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $42000.0 (down 26.32% YoY) and the FY2025 annual result came in at $51000.0, down 8.93% from the prior year.
- Other financing activities was $17000.0 for Q1 2026 at Scynexis, down from $25000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $38000.0 in Q3 2023 and bottomed at $4000.0 in Q1 2023.
- A 5-year average of $20444.4 and a median of $25000.0 in 2024 frame the typical range for Other financing activities.
- Annual changes were most pronounced in 2023 — Other financing activities plunged 60.0% — and 2024, when it jumped 525.0%.
- Scynexis' Other financing activities stood at $8000.0 in 2022, then jumped by 375.0% to $38000.0 in 2023, then declined by 18.42% to $31000.0 in 2024, then slipped by 19.35% to $25000.0 in 2025, then plunged by 32.0% to $17000.0 in 2026.
- Business Quant data shows SCYX's Other financing activities at $17000.0 in Q1 2026, $25000.0 in Q3 2025, and $26000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Scynexis | 21.55 Mn | -15.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17,000.00 |
| Mar 31, 2026 | 17,000.00 |
| Sep 30, 2025 | 25,000.00 |
| Sep 30, 2025 | 25,000.00 |
| Mar 31, 2025 | 26,000.00 |
| Mar 31, 2025 | 26,000.00 |
| Sep 30, 2024 | 31,000.00 |
| Sep 30, 2024 | 31,000.00 |
| Mar 31, 2024 | 25,000.00 |
| Mar 31, 2024 | 25,000.00 |
| Sep 30, 2023 | 38,000.00 |
| Sep 30, 2023 | 38,000.00 |
| Mar 31, 2023 | 4,000.00 |
| Mar 31, 2023 | 4,000.00 |
| Sep 30, 2022 | 8,000.00 |
| Sep 30, 2022 | 8,000.00 |
| Mar 31, 2022 | 10,000.00 |
| Mar 31, 2022 | 10,000.00 |
| Sep 30, 2021 | 13,000.00 |
| Sep 30, 2021 | 13,000.00 |